According to Latest Study, the global market for Anti-erectile Dysfunction (ED) Drugs should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Anti-erectile Dysfunction (ED) Drugs market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030. The United States Anti-erectile Dysfunction (ED) Drugs market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

By segment, Hospital grew percent to account for percent of the total market sales, and Retail Pharmacy grew percent.

This report studies and analyses global Anti-erectile Dysfunction (ED) Drugs status and future trends, helps the client to determine the Anti-erectile Dysfunction (ED) Drugs market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Anti-erectile Dysfunction (ED) Drugs, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2022 as the base year.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

To assess the competitive environment within the market including supplier revenue, market share, and company profiles.

Highlights

(1) Global Anti-erectile Dysfunction (ED) Drugs market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (K Units)

(2) Global Anti-erectile Dysfunction (ED) Drugs sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)

(3) China Anti-erectile Dysfunction (ED) Drugs sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)

(4) Global Anti-erectile Dysfunction (ED) Drugs key consuming regions, consumption quantity, consumption value and demand structure

(5) Global Anti-erectile Dysfunction (ED) Drugs key producing regions, capacity, production, and year over year growth

(6) Anti-erectile Dysfunction (ED) Drugs industry chains, upstream, midstream and downstream

Market segment by players, this report covers

Vivus, Inc.

Lilly ICOS LLC

Pfizer

Bayer

Hims

Menarini Group

Lupin

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd

General Factory

CSBio

Dong-A ST

Metuchen Pharma

Seoul Pharma

Teva Pharma

S.K. Chemicals

Market segment by Type, covers

Sildenafil (Viagra)

Vardenafil (Levitra, Staxyn)

Tadalafil (Cialis)

Avanafil (Stendra)

Udenafil (Zydena)

Others

Market segment by Application, can be divided into

Hospital

Retail Pharmacy

Clinic

Online Pharmacy

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa

Report Includes:

Chapter 1: to describe Anti-erectile Dysfunction (ED) Drugs product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.

Chapter 2: Global Anti-erectile Dysfunction (ED) Drugs market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023

Chapter 3: China Anti-erectile Dysfunction (ED) Drugs market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023

Chapter 4: Global key producing regions of Anti-erectile Dysfunction (ED) Drugs, percent & CAGR, 2018-2029

Chapter 5: Anti-erectile Dysfunction (ED) Drugs industry chain, upstream, medium-stream, and downstream.

Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029

Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029

Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029

Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029

Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.

Chapter 11: Conclusions

1 Market Overview

1.1 Anti-erectile Dysfunction (ED) Drugs Definition

1.2 Global Anti-erectile Dysfunction (ED) Drugs Market Size and Forecast

1.2.1 By Consumption Value, Global Anti-erectile Dysfunction (ED) Drugs Market Size，2019-2030

1.2.2 By Sales Quantity, Global Anti-erectile Dysfunction (ED) Drugs Market Size，2019-2030

1.2.3 Global Anti-erectile Dysfunction (ED) Drugs Average Selling Price (ASP)，2019-2030

1.3 China Anti-erectile Dysfunction (ED) Drugs Market Size and Forecast

1.3.1 By Consumption Value, China Anti-erectile Dysfunction (ED) Drugs Market Size，2019-2030

1.3.2 By Sales Quantity, China Anti-erectile Dysfunction (ED) Drugs Market Size，2019-2030

1.3.3 China Anti-erectile Dysfunction (ED) Drugs Average Selling Price (ASP)， 2019-2030

1.4 Share of China Anti-erectile Dysfunction (ED) Drugs Market with Respect to the Global Market

1.4.1 By Consumption Value, China Anti-erectile Dysfunction (ED) Drugs Market Share in Global, 2019-2030

1.4.2 By Sales Quantity, China Anti-erectile Dysfunction (ED) Drugs Market Share in Global, 2019-2030

1.4.3 Anti-erectile Dysfunction (ED) Drugs Market Size: China VS Global, 2019-2030

1.5 Anti-erectile Dysfunction (ED) Drugs Market Dynamics

1.5.1 Anti-erectile Dysfunction (ED) Drugs Market Drivers

1.5.2 Anti-erectile Dysfunction (ED) Drugs Market Restraints

1.5.3 Anti-erectile Dysfunction (ED) Drugs Industry Trends

1.5.4 Anti-erectile Dysfunction (ED) Drugs Industry Policy

2 Global Leading Manufacturers and Market Share

2.1 By Revenue of Anti-erectile Dysfunction (ED) Drugs, Global Market Share by Company, 2019-2024

2.2 By Sales Quantity of Anti-erectile Dysfunction (ED) Drugs, Global Market Share by Company, 2019-2024

2.3 Anti-erectile Dysfunction (ED) Drugs Average Selling Price (ASP) by Company, 2019-2024

2.4 Global Anti-erectile Dysfunction (ED) Drugs Participants, Market Position (Tier 1, Tier 2, and Tier 3)

2.5 Global Anti-erectile Dysfunction (ED) Drugs Concentration Ratio

2.6 Global Anti-erectile Dysfunction (ED) Drugs Mergers & Acquisitions, Expansion Plans

2.7 Global Anti-erectile Dysfunction (ED) Drugs Manufacturers Product Type

2.8 Head Office and Anti-erectile Dysfunction (ED) Drugs Production Site of Key Manufacturer

2.9 Anti-erectile Dysfunction (ED) Drugs Capacity of Major Manufacturers and Future Plan

3 China Leading Manufacturers and Market Share

3.1 By Revenue of Anti-erectile Dysfunction (ED) Drugs, China Market Share by Company, 2019-2024

3.2 By Sales Quantity of Anti-erectile Dysfunction (ED) Drugs, China Market Share by Company, 2019-2024

3.3 China Anti-erectile Dysfunction (ED) Drugs Participants, Market Position (Tier 1, Tier 2, and Tier 3)

4 Global Producing Regions

4.1 Global Anti-erectile Dysfunction (ED) Drugs Capacity, Output and Capacity Utilization, 2019-2030

4.2 Global Anti-erectile Dysfunction (ED) Drugs Capacity by Region

4.3 Global Anti-erectile Dysfunction (ED) Drugs Production & Forecast by Region, 2019 VS 2024 VS 2030

4.4 Global Anti-erectile Dysfunction (ED) Drugs Production by Region, 2019-2030

4.5 Global Anti-erectile Dysfunction (ED) Drugs Production Market Share & Forecast by Region, 2019-2030

5 Industry Chain Analysis

5.1 Anti-erectile Dysfunction (ED) Drugs Industry Chain

5.2 Anti-erectile Dysfunction (ED) Drugs Upstream Analysis

5.2.1 Anti-erectile Dysfunction (ED) Drugs Core Raw Materials

5.2.2 Main Manufacturers of Anti-erectile Dysfunction (ED) Drugs Core Raw Materials

5.3 Midstream Analysis

5.4 Downstream Analysis

5.5 Anti-erectile Dysfunction (ED) Drugs Production Mode

5.6 Anti-erectile Dysfunction (ED) Drugs Procurement Model

5.7 Anti-erectile Dysfunction (ED) Drugs Industry Sales Model and Sales Channels

5.7.1 Anti-erectile Dysfunction (ED) Drugs Sales Model

5.7.2 Anti-erectile Dysfunction (ED) Drugs Typical Distributors

6 Sights by Type

6.1 Anti-erectile Dysfunction (ED) Drugs Classification

6.1.1 Sildenafil (Viagra)

6.1.2 Vardenafil (Levitra, Staxyn)

6.1.3 Tadalafil (Cialis)

6.1.4 Avanafil (Stendra)

6.1.5 Udenafil (Zydena)

6.1.6 Others

6.2 By Type, Global Anti-erectile Dysfunction (ED) Drugs Consumption Value & CAGR, 2019 VS 2024 VS 2030

6.3 By Type, Global Anti-erectile Dysfunction (ED) Drugs Consumption Value, 2019-2030

6.4 By Type, Global Anti-erectile Dysfunction (ED) Drugs Sales Quantity, 2019-2030

6.5 By Type, Global Anti-erectile Dysfunction (ED) Drugs Average Selling Price (ASP), 2019-2030

7 Sights by Application

7.1 Anti-erectile Dysfunction (ED) Drugs Segment by Application

7.1.1 Hospital

7.1.2 Retail Pharmacy

7.1.3 Clinic

7.1.4 Online Pharmacy

7.2 By Application, Global Anti-erectile Dysfunction (ED) Drugs Consumption Value & CAGR, 2019 VS 2024 VS 2030

7.3 By Application, Global Anti-erectile Dysfunction (ED) Drugs Consumption Value, 2019-2030

7.4 By Application, Global Anti-erectile Dysfunction (ED) Drugs Sales Quantity, 2019-2030

7.5 By Application, Global Anti-erectile Dysfunction (ED) Drugs Price, 2019-2030

8 Sales Sights by Region

8.1 By Region, Global Anti-erectile Dysfunction (ED) Drugs Consumption Value, 2019 VS 2024 VS 2030

8.2 By Region, Global Anti-erectile Dysfunction (ED) Drugs Consumption Value, 2019-2030

8.3 By Region, Global Anti-erectile Dysfunction (ED) Drugs Sales Quantity, 2019-2030

8.4 North America

8.4.1 North America Anti-erectile Dysfunction (ED) Drugs & Forecasts, 2019-2030

8.4.2 By Country, North America Anti-erectile Dysfunction (ED) Drugs Market Size Market Share

8.5 Europe

8.5.1 Europe Anti-erectile Dysfunction (ED) Drugs Market Size & Forecasts, 2019-2030

8.5.2 By Country, Europe Anti-erectile Dysfunction (ED) Drugs Market Size Market Share

8.6 Asia Pacific

8.6.1 Asia Pacific Anti-erectile Dysfunction (ED) Drugs Market Size & Forecasts, 2019-2030

8.6.2 By Country/Region, Asia Pacific Anti-erectile Dysfunction (ED) Drugs Market Size Market Share

8.7 South America

8.7.1 South America Anti-erectile Dysfunction (ED) Drugs Market Size & Forecasts, 2019-2030

8.7.2 By Country, South America Anti-erectile Dysfunction (ED) Drugs Market Size Market Share

8.8 Middle East & Africa

9 Sales Sights by Country Level

9.1 By Country, Global Anti-erectile Dysfunction (ED) Drugs Market Size & CAGR, 2019 VS 2024 VS 2030

9.2 By Country, Global Anti-erectile Dysfunction (ED) Drugs Consumption Value, 2019-2030

9.3 By Country, Global Anti-erectile Dysfunction (ED) Drugs Sales Quantity, 2019-2030

9.4 U.S.

9.4.1 U.S. Anti-erectile Dysfunction (ED) Drugs Market Size, 2019-2030

9.4.2 By Type, U.S. Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share, 2022 VS 2029

9.4.3 By Application, U.S. Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share, 2022 VS 2029

9.5 Europe

9.5.1 Europe Anti-erectile Dysfunction (ED) Drugs Market Size, 2019-2030

9.5.2 By Type, Europe Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share, 2022 VS 2029

9.5.3 By Application, Europe Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share, 2022 VS 2029

9.6 China

9.6.1 China Anti-erectile Dysfunction (ED) Drugs Market Size, 2019-2030

9.6.2 By Type, China Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share, 2022 VS 2029

9.6.3 By Application, China Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share, 2022 VS 2029

9.7 Japan

9.7.1 Japan Anti-erectile Dysfunction (ED) Drugs Market Size, 2019-2030

9.7.2 By Type, Japan Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share, 2022 VS 2029

9.7.3 By Application, Japan Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share, 2022 VS 2029

9.8 South Korea

9.8.1 South Korea Anti-erectile Dysfunction (ED) Drugs Market Size, 2019-2030

9.8.2 By Type, South Korea Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share, 2022 VS 2029

9.8.3 By Application, South Korea Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share, 2022 VS 2029

9.9 Southeast Asia

9.9.1 Southeast Asia Anti-erectile Dysfunction (ED) Drugs Market Size, 2019-2030

9.9.2 By Type, Southeast Asia Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share, 2022 VS 2029

9.9.3 By Application, Southeast Asia Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share, 2022 VS 2029

9.10 India

9.10.1 India Anti-erectile Dysfunction (ED) Drugs Market Size, 2019-2030

9.10.2 By Type, India Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share, 2022 VS 2029

9.10.3 By Application, India Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share, 2022 VS 2029

9.11 Middle East & Africa

9.11.1 Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Market Size, 2019-2030

9.11.2 By Type, Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share, 2022 VS 2029

9.11.3 By Application, Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share, 2022 VS 2029

10 Manufacturers Profile

10.1 Vivus, Inc.

10.1.1 Vivus, Inc. Company Information, Head Office, Market Area, and Industry Position

10.1.2 Vivus, Inc. Anti-erectile Dysfunction (ED) Drugs Models, Specifications, and Application

10.1.3 Vivus, Inc. Anti-erectile Dysfunction (ED) Drugs Sales Quantity, Revenue, Price and Gross Margin, 2019-2024

10.1.4 Vivus, Inc. Company Profile and Main Business

10.1.5 Vivus, Inc. Recent Developments

10.2 Lilly ICOS LLC

10.2.1 Lilly ICOS LLC Company Information, Head Office, Market Area, and Industry Position

10.2.2 Lilly ICOS LLC Anti-erectile Dysfunction (ED) Drugs Models, Specifications, and Application

10.2.3 Lilly ICOS LLC Anti-erectile Dysfunction (ED) Drugs Sales Quantity, Revenue, Price and Gross Margin, 2019-2024

10.2.4 Lilly ICOS LLC Company Profile and Main Business

10.2.5 Lilly ICOS LLC Recent Developments

10.3 Pfizer

10.3.1 Pfizer Company Information, Head Office, Market Area, and Industry Position

10.3.2 Pfizer Anti-erectile Dysfunction (ED) Drugs Models, Specifications, and Application

10.3.3 Pfizer Anti-erectile Dysfunction (ED) Drugs Sales Quantity, Revenue, Price and Gross Margin, 2019-2024

10.3.4 Pfizer Company Profile and Main Business

10.3.5 Pfizer Recent Developments

10.4 Bayer

10.4.1 Bayer Company Information, Head Office, Market Area, and Industry Position

10.4.2 Bayer Anti-erectile Dysfunction (ED) Drugs Models, Specifications, and Application

10.4.3 Bayer Anti-erectile Dysfunction (ED) Drugs Sales Quantity, Revenue, Price and Gross Margin, 2019-2024

10.4.4 Bayer Company Profile and Main Business

10.4.5 Bayer Recent Developments

10.5 Hims

10.5.1 Hims Company Information, Head Office, Market Area, and Industry Position

10.5.2 Hims Anti-erectile Dysfunction (ED) Drugs Models, Specifications, and Application

10.5.3 Hims Anti-erectile Dysfunction (ED) Drugs Sales Quantity, Revenue, Price and Gross Margin, 2019-2024

10.5.4 Hims Company Profile and Main Business

10.5.5 Hims Recent Developments

10.6 Menarini Group

10.6.1 Menarini Group Company Information, Head Office, Market Area, and Industry Position

10.6.2 Menarini Group Anti-erectile Dysfunction (ED) Drugs Models, Specifications, and Application

10.6.3 Menarini Group Anti-erectile Dysfunction (ED) Drugs Sales Quantity, Revenue, Price and Gross Margin, 2019-2024

10.6.4 Menarini Group Company Profile and Main Business

10.6.5 Menarini Group Recent Developments

10.7 Lupin

10.7.1 Lupin Company Information, Head Office, Market Area, and Industry Position

10.7.2 Lupin Anti-erectile Dysfunction (ED) Drugs Models, Specifications, and Application

10.7.3 Lupin Anti-erectile Dysfunction (ED) Drugs Sales Quantity, Revenue, Price and Gross Margin, 2019-2024

10.7.4 Lupin Company Profile and Main Business

10.7.5 Lupin Recent Developments

10.8 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd

10.8.1 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Company Information, Head Office, Market Area, and Industry Position

10.8.2 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Anti-erectile Dysfunction (ED) Drugs Models, Specifications, and Application

10.8.3 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Anti-erectile Dysfunction (ED) Drugs Sales Quantity, Revenue, Price and Gross Margin, 2019-2024

10.8.4 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Company Profile and Main Business

10.8.5 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Recent Developments

10.9 General Factory

10.9.1 General Factory Company Information, Head Office, Market Area, and Industry Position

10.9.2 General Factory Anti-erectile Dysfunction (ED) Drugs Models, Specifications, and Application

10.9.3 General Factory Anti-erectile Dysfunction (ED) Drugs Sales Quantity, Revenue, Price and Gross Margin, 2019-2024

10.9.4 General Factory Company Profile and Main Business

10.9.5 General Factory Recent Developments

10.10 CSBio

10.10.1 CSBio Company Information, Head Office, Market Area, and Industry Position

10.10.2 CSBio Anti-erectile Dysfunction (ED) Drugs Models, Specifications, and Application

10.10.3 CSBio Anti-erectile Dysfunction (ED) Drugs Sales Quantity, Revenue, Price and Gross Margin, 2019-2024

10.10.4 CSBio Company Profile and Main Business

10.10.5 CSBio Recent Developments

10.11 Dong-A ST

10.11.1 Dong-A ST Company Information, Head Office, Market Area, and Industry Position

10.11.2 Dong-A ST Anti-erectile Dysfunction (ED) Drugs Models, Specifications, and Application

10.11.3 Dong-A ST Anti-erectile Dysfunction (ED) Drugs Sales Quantity, Revenue, Price and Gross Margin, 2019-2024

10.11.4 Dong-A ST Company Profile and Main Business

10.11.5 Dong-A ST Recent Developments

10.12 Metuchen Pharma

10.12.1 Metuchen Pharma Company Information, Head Office, Market Area, and Industry Position

10.12.2 Metuchen Pharma Anti-erectile Dysfunction (ED) Drugs Models, Specifications, and Application

10.12.3 Metuchen Pharma Anti-erectile Dysfunction (ED) Drugs Sales Quantity, Revenue, Price and Gross Margin, 2019-2024

10.12.4 Metuchen Pharma Company Profile and Main Business

10.12.5 Metuchen Pharma Recent Developments

10.13 Seoul Pharma

10.13.1 Seoul Pharma Company Information, Head Office, Market Area, and Industry Position

10.13.2 Seoul Pharma Anti-erectile Dysfunction (ED) Drugs Models, Specifications, and Application

10.13.3 Seoul Pharma Anti-erectile Dysfunction (ED) Drugs Sales Quantity, Revenue, Price and Gross Margin, 2019-2024

10.13.4 Seoul Pharma Company Profile and Main Business

10.13.5 Seoul Pharma Recent Developments

10.14 Teva Pharma

10.14.1 Teva Pharma Company Information, Head Office, Market Area, and Industry Position

10.14.2 Teva Pharma Anti-erectile Dysfunction (ED) Drugs Models, Specifications, and Application

10.14.3 Teva Pharma Anti-erectile Dysfunction (ED) Drugs Sales Quantity, Revenue, Price and Gross Margin, 2019-2024

10.14.4 Teva Pharma Company Profile and Main Business

10.14.5 Teva Pharma Recent Developments

10.15 S.K. Chemicals

10.15.1 S.K. Chemicals Company Information, Head Office, Market Area, and Industry Position

10.15.2 S.K. Chemicals Anti-erectile Dysfunction (ED) Drugs Models, Specifications, and Application

10.15.3 S.K. Chemicals Anti-erectile Dysfunction (ED) Drugs Sales Quantity, Revenue, Price and Gross Margin, 2019-2024

10.15.4 S.K. Chemicals Company Profile and Main Business

10.15.5 S.K. Chemicals Recent Developments

11 Conclusion

12 Appendix

12.1 Research Methodology

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Market Estimation Model

12.4 Disclaimer

Table 1. Anti-erectile Dysfunction (ED) Drugs Consumption Value & CAGR: China VS Global, 2019-2030, US$ Million

Table 2. Anti-erectile Dysfunction (ED) Drugs Market Restraints

Table 3. Anti-erectile Dysfunction (ED) Drugs Market Trends

Table 4. Anti-erectile Dysfunction (ED) Drugs Industry Policy

Table 5. Global Anti-erectile Dysfunction (ED) Drugs Revenue by Company, 2019-2024, US$ million, Ranked Based on Revenue in 2022

Table 6. Global Anti-erectile Dysfunction (ED) Drugs Revenue Share by Company, 2019-2024, Ranked by Data of 2022

Table 7. Global Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Company, (2019-2024) & (K Units), Ranked Based on Sales in 2022

Table 8. Global Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Company, 2019-2024, Ranked by Data of 2022

Table 9. Global Anti-erectile Dysfunction (ED) Drugs Average Selling Price (ASP) by Company, (2019-2024) & (US$/Unit)

Table 10. Global Anti-erectile Dysfunction (ED) Drugs Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Anti-erectile Dysfunction (ED) Drugs Mergers & Acquisitions, Expansion Plans

Table 12. Global Anti-erectile Dysfunction (ED) Drugs Manufacturers Product Type

Table 13. Head Office and Anti-erectile Dysfunction (ED) Drugs Production Site of Key Manufacturer

Table 14. Anti-erectile Dysfunction (ED) Drugs Capacity of Major Manufacturers and Future Plan

Table 15. China Anti-erectile Dysfunction (ED) Drugs Revenue by Company, 2019-2024, US$ million, Ranked Based on Revenue in 2022

Table 16. China Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Company, (2019-2024) & (K Units), Ranked Based on Sales in 2022

Table 17. China Anti-erectile Dysfunction (ED) Drugs Sales Quantity by Company, 2019-2024, Ranked by Data of 2022

Table 18. Global Anti-erectile Dysfunction (ED) Drugs Production & Forecast by Region, 2019 VS 2024 VS 2030, (K Units)

Table 19. Global Anti-erectile Dysfunction (ED) Drugs Production by Region, 2019-2024, (K Units)

Table 20. Global Anti-erectile Dysfunction (ED) Drugs Production Forecast by Region, 2024-2029, (K Units)

Table 21. Global Key Players of Anti-erectile Dysfunction (ED) Drugs Upstream (Raw Materials)

Table 22. Global Anti-erectile Dysfunction (ED) Drugs Typical Customers

Table 23. Anti-erectile Dysfunction (ED) Drugs Typical Distributors

Table 24. By Type, Global Anti-erectile Dysfunction (ED) Drugs Consumption Value & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 25. By Application, Global Anti-erectile Dysfunction (ED) Drugs Consumption Value & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 26. By Region, Global Anti-erectile Dysfunction (ED) Drugs Consumption Value, 2019 VS 2024 VS 2030, US$ Million

Table 27. By Region, Global Anti-erectile Dysfunction (ED) Drugs Consumption Value, 2019-2030, US$ Million

Table 28. By Region, Global Anti-erectile Dysfunction (ED) Drugs Sales Quantity, 2019-2030, (K Units)

Table 29. By Country, Global Anti-erectile Dysfunction (ED) Drugs Consumption Value & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 30. By Country, Global Anti-erectile Dysfunction (ED) Drugs Consumption Value, 2019-2030, US$ Million

Table 31. By Country, Global Anti-erectile Dysfunction (ED) Drugs Consumption Value Market Share, 2019-2030

Table 32. By Country, Global Anti-erectile Dysfunction (ED) Drugs Sales Quantity, 2019-2030, (K Units)

Table 33. By Country, Global Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share, 2019-2030

Table 34. Vivus, Inc. Company Information, Head Office, Market Area, and Industry Position

Table 35. Vivus, Inc. Anti-erectile Dysfunction (ED) Drugs Models, Specifications, and Application

Table 36. Vivus, Inc. Anti-erectile Dysfunction (ED) Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 37. Vivus, Inc. Company Profile and Main Business

Table 38. Vivus, Inc. Recent Developments

Table 39. Lilly ICOS LLC Company Information, Head Office, Market Area, and Industry Position

Table 40. Lilly ICOS LLC Anti-erectile Dysfunction (ED) Drugs Models, Specifications, and Application

Table 41. Lilly ICOS LLC Anti-erectile Dysfunction (ED) Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 42. Lilly ICOS LLC Company Profile and Main Business

Table 43. Lilly ICOS LLC Recent Developments

Table 44. Pfizer Company Information, Head Office, Market Area, and Industry Position

Table 45. Pfizer Anti-erectile Dysfunction (ED) Drugs Models, Specifications, and Application

Table 46. Pfizer Anti-erectile Dysfunction (ED) Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 47. Pfizer Company Profile and Main Business

Table 48. Pfizer Recent Developments

Table 49. Bayer Company Information, Head Office, Market Area, and Industry Position

Table 50. Bayer Anti-erectile Dysfunction (ED) Drugs Models, Specifications, and Application

Table 51. Bayer Anti-erectile Dysfunction (ED) Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 52. Bayer Company Profile and Main Business

Table 53. Bayer Recent Developments

Table 54. Hims Company Information, Head Office, Market Area, and Industry Position

Table 55. Hims Anti-erectile Dysfunction (ED) Drugs Models, Specifications, and Application

Table 56. Hims Anti-erectile Dysfunction (ED) Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 57. Hims Company Profile and Main Business

Table 58. Hims Recent Developments

Table 59. Menarini Group Company Information, Head Office, Market Area, and Industry Position

Table 60. Menarini Group Anti-erectile Dysfunction (ED) Drugs Models, Specifications, and Application

Table 61. Menarini Group Anti-erectile Dysfunction (ED) Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 62. Menarini Group Company Profile and Main Business

Table 63. Menarini Group Recent Developments

Table 64. Lupin Company Information, Head Office, Market Area, and Industry Position

Table 65. Lupin Anti-erectile Dysfunction (ED) Drugs Models, Specifications, and Application

Table 66. Lupin Anti-erectile Dysfunction (ED) Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 67. Lupin Company Profile and Main Business

Table 68. Lupin Recent Developments

Table 69. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Company Information, Head Office, Market Area, and Industry Position

Table 70. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Anti-erectile Dysfunction (ED) Drugs Models, Specifications, and Application

Table 71. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Anti-erectile Dysfunction (ED) Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 72. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Company Profile and Main Business

Table 73. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Recent Developments

Table 74. General Factory Company Information, Head Office, Market Area, and Industry Position

Table 75. General Factory Anti-erectile Dysfunction (ED) Drugs Models, Specifications, and Application

Table 76. General Factory Anti-erectile Dysfunction (ED) Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 77. General Factory Company Profile and Main Business

Table 78. General Factory Recent Developments

Table 79. CSBio Company Information, Head Office, Market Area, and Industry Position

Table 80. CSBio Anti-erectile Dysfunction (ED) Drugs Models, Specifications, and Application

Table 81. CSBio Anti-erectile Dysfunction (ED) Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 82. CSBio Company Profile and Main Business

Table 83. CSBio Recent Developments

Table 84. Dong-A ST Company Information, Head Office, Market Area, and Industry Position

Table 85. Dong-A ST Anti-erectile Dysfunction (ED) Drugs Models, Specifications, and Application

Table 86. Dong-A ST Anti-erectile Dysfunction (ED) Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 87. Dong-A ST Company Profile and Main Business

Table 88. Dong-A ST Recent Developments

Table 89. Metuchen Pharma Company Information, Head Office, Market Area, and Industry Position

Table 90. Metuchen Pharma Anti-erectile Dysfunction (ED) Drugs Models, Specifications, and Application

Table 91. Metuchen Pharma Anti-erectile Dysfunction (ED) Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 92. Metuchen Pharma Company Profile and Main Business

Table 93. Metuchen Pharma Recent Developments

Table 94. Seoul Pharma Company Information, Head Office, Market Area, and Industry Position

Table 95. Seoul Pharma Anti-erectile Dysfunction (ED) Drugs Models, Specifications, and Application

Table 96. Seoul Pharma Anti-erectile Dysfunction (ED) Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 97. Seoul Pharma Company Profile and Main Business

Table 98. Seoul Pharma Recent Developments

Table 99. Teva Pharma Company Information, Head Office, Market Area, and Industry Position

Table 100. Teva Pharma Anti-erectile Dysfunction (ED) Drugs Models, Specifications, and Application

Table 101. Teva Pharma Anti-erectile Dysfunction (ED) Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 102. Teva Pharma Company Profile and Main Business

Table 103. Teva Pharma Recent Developments

Table 104. S.K. Chemicals Company Information, Head Office, Market Area, and Industry Position

Table 105. S.K. Chemicals Anti-erectile Dysfunction (ED) Drugs Models, Specifications, and Application

Table 106. S.K. Chemicals Anti-erectile Dysfunction (ED) Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 107. S.K. Chemicals Company Profile and Main Business

Table 108. S.K. Chemicals Recent Developments

List of Figures

Figure 1. Anti-erectile Dysfunction (ED) Drugs Picture

Figure 2. Global Anti-erectile Dysfunction (ED) Drugs Consumption Value, (US$ million) & (2019-2030)

Figure 3. Global Anti-erectile Dysfunction (ED) Drugs Sales Quantity, (K Units) & (2019-2030)

Figure 4. Global Anti-erectile Dysfunction (ED) Drugs Average Selling Price (ASP), (2019-2030) & (US$/Unit)

Figure 5. China Anti-erectile Dysfunction (ED) Drugs Consumption Value, (US$ million) & (2019-2030)

Figure 6. China Anti-erectile Dysfunction (ED) Drugs Sales Quantity (K Units) & (2019-2030)

Figure 7. China Anti-erectile Dysfunction (ED) Drugs Average Selling Price (ASP), (US$/Unit) & (2019-2030)

Figure 8. By Consumption Value, China Anti-erectile Dysfunction (ED) Drugs Market Share of Global, 2019-2030

Figure 9. By Sales Quantity, China Anti-erectile Dysfunction (ED) Drugs Market Share of Global, 2019-2030

Figure 10. Global Anti-erectile Dysfunction (ED) Drugs Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022

Figure 11. China Anti-erectile Dysfunction (ED) Drugs Key Participants, Market Share, 2022

Figure 12. Global Anti-erectile Dysfunction (ED) Drugs Capacity, Production and Capacity Utilization, 2019-2030

Figure 13. Global Anti-erectile Dysfunction (ED) Drugs Capacity Market Share by Region, 2022 VS 2029

Figure 14. Global Anti-erectile Dysfunction (ED) Drugs Production Market Share & Forecast by Region, 2019-2030

Figure 15. Anti-erectile Dysfunction (ED) Drugs Industry Chain

Figure 16. Anti-erectile Dysfunction (ED) Drugs Procurement Model

Figure 17. Anti-erectile Dysfunction (ED) Drugs Sales Model

Figure 18. Anti-erectile Dysfunction (ED) Drugs Sales Channels, Direct Sales, and Distribution

Figure 19. Sildenafil (Viagra)

Figure 20. Vardenafil (Levitra, Staxyn)

Figure 21. Tadalafil (Cialis)

Figure 22. Avanafil (Stendra)

Figure 23. Udenafil (Zydena)

Figure 24. Others

Figure 25. By Type, Global Anti-erectile Dysfunction (ED) Drugs Consumption Value, 2019-2030, US$ Million

Figure 26. By Type, Global Anti-erectile Dysfunction (ED) Drugs Consumption Value Market Share, 2019-2030

Figure 27. By Type, Global Anti-erectile Dysfunction (ED) Drugs Sales Quantity, 2019-2030, (K Units)

Figure 28. By Type, Global Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share, 2019-2030

Figure 29. By Type, Global Anti-erectile Dysfunction (ED) Drugs Average Selling Price (ASP), 2019-2030, (US$/Unit)

Figure 30. Hospital

Figure 31. Retail Pharmacy

Figure 32. Clinic

Figure 33. Online Pharmacy

Figure 34. By Application, Global Anti-erectile Dysfunction (ED) Drugs Consumption Value, 2019-2030, US$ Million

Figure 35. By Application, Global Anti-erectile Dysfunction (ED) Drugs Consumption Value Market Share, 2019-2030

Figure 36. By Application, Global Anti-erectile Dysfunction (ED) Drugs Sales Quantity, 2019-2030, (K Units)

Figure 37. By Application, Global Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share, 2019-2030

Figure 38. By Application, Global Anti-erectile Dysfunction (ED) Drugs Average Selling Price (ASP), 2019-2030, (US$/Unit)

Figure 39. By Region, Global Anti-erectile Dysfunction (ED) Drugs Consumption Value Market Share, 2019-2030

Figure 40. By Region, Global Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share, 2019-2030

Figure 41. North America Anti-erectile Dysfunction (ED) Drugs Consumption Value & Forecasts, 2019-2030, US$ Million

Figure 42. By Country, North America Anti-erectile Dysfunction (ED) Drugs Consumption Value Market Share, 2022

Figure 43. Europe Anti-erectile Dysfunction (ED) Drugs Consumption Value & Forecasts, 2019-2030, US$ Million

Figure 44. By Country, Europe Anti-erectile Dysfunction (ED) Drugs Consumption Value Market Share, 2022

Figure 45. Asia Pacific Anti-erectile Dysfunction (ED) Drugs Consumption Value & Forecasts, 2019-2030, US$ Million

Figure 46. By Country/Region, Asia Pacific Anti-erectile Dysfunction (ED) Drugs Consumption Value Market Share, 2022

Figure 47. South America Anti-erectile Dysfunction (ED) Drugs Consumption Value & Forecasts, 2019-2030, US$ Million

Figure 48. By Country, South America Anti-erectile Dysfunction (ED) Drugs Consumption Value Market Share, 2022

Figure 49. Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Consumption Value & Forecasts, 2019-2030, US$ Million

Figure 50. U.S. Anti-erectile Dysfunction (ED) Drugs Sales Quantity, 2019-2030, (K Units)

Figure 51. By Type, U.S. Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share, 2022 VS 2029

Figure 52. By Application, U.S. Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share, 2022 VS 2029

Figure 53. Europe Anti-erectile Dysfunction (ED) Drugs Sales Quantity, 2019-2030, (K Units)

Figure 54. By Type, Europe Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share, 2022 VS 2029

Figure 55. By Application, Europe Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share, 2022 VS 2029

Figure 56. China Anti-erectile Dysfunction (ED) Drugs Sales Quantity, 2019-2030, (K Units)

Figure 57. By Type, China Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share, 2022 VS 2029

Figure 58. By Application, China Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share, 2022 VS 2029

Figure 59. Japan Anti-erectile Dysfunction (ED) Drugs Sales Quantity, 2019-2030, (K Units)

Figure 60. By Type, Japan Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share, 2022 VS 2029

Figure 61. By Application, Japan Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share, 2022 VS 2029

Figure 62. South Korea Anti-erectile Dysfunction (ED) Drugs Sales Quantity, 2019-2030, (K Units)

Figure 63. By Type, South Korea Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share, 2022 VS 2029

Figure 64. By Application, South Korea Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share, 2022 VS 2029

Figure 65. Southeast Asia Anti-erectile Dysfunction (ED) Drugs Sales Quantity, 2019-2030, (K Units)

Figure 66. By Type, Southeast Asia Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share, 2022 VS 2029

Figure 67. By Application, Southeast Asia Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share, 2022 VS 2029

Figure 68. India Anti-erectile Dysfunction (ED) Drugs Sales Quantity, 2019-2030, (K Units)

Figure 69. By Type, India Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share, 2022 VS 2029

Figure 70. By Application, India Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share, 2022 VS 2029

Figure 71. Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Sales Quantity, 2019-2030, (K Units)

Figure 72. By Type, Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share, 2022 VS 2029

Figure 73. By Application, Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Sales Quantity Market Share, 2022 VS 2029

Figure 74. Research Methodology

Figure 75. Breakdown of Primary Interviews

Figure 76. Bottom-up and Top-down Approaches

Figure 77. Top-down Approaches

Methodology/Research Approach

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Research Programs/Design

Historical Data (2015-2019)	Industry Trends Competitive Landscape By Company Expansion Mergers and Acquisitions Market Segment by Type by Application By Regions/ Geography	Value Status and Outlook Value for Major Players Market Share Growth Rate Present Situation Analysis Value Market Share Growth Rate Present Situation Analysis
Influencing Factors	Market Environment Government Policy Technological Changes Market Risks	Market Drivers Growing Demand of Downstream Reduction in Cost
Market Forecast (2021-2026)	Overall Size by Type by Application By Regions/Geography	Key Data (Value) Market Share Growth Rate CAGR (2021-2026)

Market Size Estimation

Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).

The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.

Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report

The following figure shows an illustrative representation of the overall market size estimation process used for this study.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Data Source

Secondary Sources

Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.

Market Size	Segmental value Geographic Penetration Product Adoption Rate for Different market	Journals, Websites, and Press Releases Annual Reports and SEC Filings Company Websites and Press Releases Public and Paid Databases Market Intellix Data Repository
Market Position of Top Company	Product Financials Geographic value Mix Total Company value Business/Segmental value Mix
Qualitative Analysis	Influence Factors Market Potential Market Risks and Opportunities Industry Trends Geographical Features Government Policies	Company Websites and Press Releases Public and Paid Databases Annual Reports Industry Associations Market Intellix Data Repository

Primary Sources

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.

Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.

Key Executives Interviewed

Key Data Information from Primary Sources

Primary Sources	Parameters	Key Data
Market Segments(by Application, by Type)	Value by Type Status and Forecast Value by Application Value by Regions, Status and Forecast (2021-2026)	Value Market Share by Type Value Growth Rate by Type Value by Application Percentage and Growth Rate by Application Value Growth Rate and Market Share by Regions Market Size Status and Forecast (2021-2026)
Total Market	Overall Size, Status and Forecast	Market Size Status and Forecast (2021-2026)